International consensus on the use of tau PET imaging agent (18)F-flortaucipir in Alzheimer’s disease

PURPOSE: Positron emission tomography (PET) with the first and only tau targeting radiotracer of (18)F-flortaucipir approved by FDA has been increasingly used in depicting tau pathology deposition and distribution in patients with cognitive impairment. The goal of this international consensus is to...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Mei, Civelek, A. Cahid, Carrio, Ignasi, Watanabe, Yasuyoshi, Kang, Keon Wook, Murakami, Koji, Garibotto, Valentina, Prior, John O., Barthel, Henryk, Zhou, Rui, Hou, Haifeng, Dou, Xiaofeng, Jin, Chentao, Zuo, Chuantao, Zhang, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Guidelines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803772/
https://www.ncbi.nlm.nih.gov/pubmed/34978595
http://dx.doi.org/10.1007/s00259-021-05673-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803772/
https://www.ncbi.nlm.nih.gov/pubmed/34978595
http://dx.doi.org/10.1007/s00259-021-05673-w

Ejemplares similares